Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novelos Therapeutics to raise $5.9m as it advances cancer-targeted compounds

This article was originally published in Clinica

Executive Summary

Novelos Therapeutics, a US company which is developing novel drugs for the treatment and diagnosis of cancer, said it will sell 9.8 million units at $0.60 per unit in an offering underwritten by Rodman & Renshaw. Each unit consists of one share of common stock and a warrant to purchase one share of stock, with warrants having an exercise price or $0.60 and a five-year term.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098248

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel